The type 1 insulin-like growth factor receptor (IGF1R) has been implicated in various aspects of tumour development and metastasis (Chitnis et al, 2008; Pollak, 2008) with overexpression of IGF1R and its ligands IGF1 and IGF2, a common finding in malignant disease (Furstenberger and Senn, 2002). Here, IGF1R is linked to neoplasm.